---
layout: default
---

## Research

### 2019

***

**Detection and quantification of GPCR mRNA: An assessment and implications of data from high-content methods**   
[BioRxiv](https://www.biorxiv.org/content/10.1101/734863v1.abstract)   
Krishna Sriram, Shu Z. Wiley, <u>Kevin Moyung</u>, Matthew W. Gorr, Cristina Salmer√≥n, Jordin Marucut, Randall P. French, Andrew M. Lowy,  Paul A. Insel   

**GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors**  
PLoS Biology (Accepted), [BioRxiv (Preprint)](https://www.biorxiv.org/content/10.1101/546481v1?rss=1)   
Krishna Sriram, <u>Kevin Moyung</u>, Ross Corriden, Hannah Carter, Paul Insel  

**High-content detection of GPCR mRNA expression: which methods work best?**  
ACS Pharmacology Translational Science. Special Issue on GPCRs (Under Review)  
Krishna Sriram, Shu Z. Wiley, Matthew W. Gorr, <u>Kevin Moyung</u>, Randall P. French, Andrew M. Lowy, Paul A. Insel  

### 2018

***

**Solid tumors have frequent mutation, copy number variation and differential mRNA expression of GPCRs: Are such
GPCRs functional oncogenes**  
[Cancer Research (Abstract)](http://cancerres.aacrjournals.org/content/78/13_Supplement/3293.short)  
Krishna Sriram, <u>Kevin Moyung</u>, Ross Corriden, Paul A. Insel

**HRH1: A Novel GPCR Drug Target in Pancreatic Cancer**  
[The FASEB Journal (Abstract)](https://www.fasebj.org/doi/abs/10.1096/fasebj.2018.32.1_supplement.695.1)  
Alyssa Rodriguez, Krishna Sriram, <u>Kevin Moyung</u>, Paul A. Insel  
